Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma

  • Authors:
    • Liang Jiang
    • Qiu‑Long Liu
    • Qi‑Lian Liang
    • Hui‑Jie Zhang
    • Wen‑Ting Ou
    • Gao‑Le Yuan
  • View Affiliations

  • Published online on: October 31, 2017     https://doi.org/10.3892/ol.2017.7302
  • Pages:545-551
Metrics: HTML 0 views | PDF 0 views
0

Abstract

Egl-9 family hypoxia-inducible factor (HIF)3/prolyl hydroxylase 3 (EGLN3/PHD3) serves a role in the progression and prognosis of cancer. PHD3 is able to induce apoptosis in HepG2 cells. In the present study, the protein levels of PHD3 and HIF2α were analyzed by western blot analysis and immunohistochemistry in 84 paired hepatocellular carcinoma (HCC) tissues and adjacent non‑tumor liver tissues. The mRNA levels of PHD3 and HIF2α were analyzed by reverse transcription-quantitative polymerase chain reaction. PHD3 was overexpressed in HCC tissues compared with adjacent liver tissues (mRNA expression: P<0.001; protein expression: P=0.003; immunohistochemistry positive rate: P=0.001). The high level of expression of PHD3 in HCC tissues was associated with good differentiation (mRNA expression: P=0.002; protein expression: P<0.001) and small tumor size (mRNA expression: P<0.001; protein expression: P=0.002). In addition, HIF2α expression was lower in HCC tissues compared with adjacent liver tissues (mRNA expression: P<0.001; protein expression: P=0.002; immunohistochemistry positive rate: P=0.002). No statistically significant associations were identified between HIF2α expression and clinicopathological characteristics. Pearson's and Spearman's correlation coefficients revealed no correlation between HIF2α and PHD3 expression in HCC. In conclusion, PHD3 expression acts as a favorable prognostic marker for patients with HCC. There is no correlation between PHD3 and HIF2α expression in HCC.

Related Articles

Journal Cover

January 2018
Volume 15 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Jiang, L., Liu, Q., Liang, Q., Zhang, H., Ou, W., & Yuan, G. (2018). Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma. Oncology Letters, 15, 545-551. https://doi.org/10.3892/ol.2017.7302
MLA
Jiang, L., Liu, Q., Liang, Q., Zhang, H., Ou, W., Yuan, G."Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma". Oncology Letters 15.1 (2018): 545-551.
Chicago
Jiang, L., Liu, Q., Liang, Q., Zhang, H., Ou, W., Yuan, G."Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma". Oncology Letters 15, no. 1 (2018): 545-551. https://doi.org/10.3892/ol.2017.7302